Survival analysis of HER2 receptor negative and HER2 receptor low breast cancer patients at a Philippine Tertiary Government Hospital
This study reveals a worse 3-year DFS in HER2 +2/FISH negative patients across both early and advanced disease stages. The findings highlight the prognostic importance of HER2-low status and may guide future therapeutic strategies, including the use of targeted therapies like T-Dxd in non-metastatic patients.
Authors
- Michael San Juan (ORCID: https://orcid.org/0000-0002-7635-4409)
- Carl Lawrence C Arenos (ORCID: https://orcid.org/0009-0001-6070-6924)
- Isabela Andrea L Reveldez
- Vincent F Tatoy
- Timothy Joseph S Uy
- Steven Lim
- Andreu Lominoque
- Angeli Sison-Dimaano
- Nehar Pagandaman
Institutions
- Twitter (United States) (US)
- Philippine General Hospital (PH)
Publication Details
- Journal
- ecancermedicalscience
- Published
- 2025-02-06
- DOI
- https://doi.org/10.3332/ecancer.2025.1840
- Citations
- 1
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.94